Please assess the completion status of the following clinical trial:

Trial Title: Seasonal Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine in Children in Mali

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 6 months to 10 years~* Agree to seek initial medical care for all medical illness in the study clinic during the study period~* Written informed consent by a parent or legal garden,~* No plan to travel for a long time during the study period.~Exclusion Criteria:~* History of allergy to sulfa drugs or Sulfadoxine-pyrimethamine~* Chronic illness or symptomatic malaria at the time of enrollment

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 10 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: NO_INTERVENTION): Control group
- 2 (Type: EXPERIMENTAL): Test group

Based on this trial design, predict the completion outcome and termination type (if applicable).